Dupilumab for management of capecitabine-induced hand-foot syndrome

Authors: Ian Nykaza, Rachel Sanford, Allison Gordon

Source: JAAD Case Reports, Vol 63, Iss, Pp 105-108 (2025)

Subject Terms: supportive care, capecitabine, dupilumab, RL1-803, hand-foot syndrome, biologics, oncodermatology, Dermatology

Access URL: https://doaj.org/article/67a45270c16e438d8e38a8d1fb4599bf

Capivasertib-induced polymorphous lichenoid exanthem: Report of a novel AKT kinase inhibitor-related drug eruption

Authors: Fadadu, Raj P, Lee, Albert, Hinds, Brian, Orme, Charisse

Source: JAAD Case Rep
JAAD Case Reports, Vol 62, Iss, Pp 96-99 (2025)

Subject Terms: breast cancer, Biomedical and Clinical Sciences, 5.1 Pharmaceuticals, RL1-803, oncology, drug, Clinical sciences, oncodermatology, Case Report, Pharmacology and Pharmaceutical Sciences, rash, Dermatology, drug eruption

File Description: application/pdf

Access URL: https://doaj.org/article/738542494897488a9c04e1246700faad
https://escholarship.org/uc/item/7cp1779g
https://escholarship.org/content/qt7cp1779g/qt7cp1779g.pdf

Loop cautery for chronic lymphangioma removal

Authors: Riyad N.H. Seervai, Lynna J. Yang, Elizabeth G. Berry

Source: JAAD Case Rep
JAAD Case Reports, Vol 60, Iss, Pp 44-47 (2025)

Subject Terms: chronic lymphedema, supportive oncodermatology, RL1-803, Case Report, Dermatology, electrosurgery, loop cautery, lymphangioma, metastatic melanoma

Access URL: https://pubmed.ncbi.nlm.nih.gov/40353089
https://doaj.org/article/48f3851c030345648e93268525a69e3a

Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting

Authors: Emma L. Myers, Jessica Liu, Sabrina M. Shearer, Sarah A. Myers, Michelle Schneider, Christopher Hoimes, Melodi Javid Whitley

Source: JAAD Case Rep
JAAD Case Reports, Vol 58, Iss, Pp 85-92 (2025)

Subject Terms: RL1-803, severe cutaneous adverse reaction, immune checkpoint inhibitor, oncodermatology, Case Series, immunotherapy, pembrolizumab, Dermatology, enfortumab

Access URL: https://pubmed.ncbi.nlm.nih.gov/40144398
https://doaj.org/article/5e4b03815fc64cf7bb48e10b4e9e76f0

A striking case of cutaneous adult T-cell leukemia/lymphoma mimicking subacute cutaneous lupus erythematosus

Authors: Daniel S. Alicea, MS, Suraj Muddasani, MD, Michael Occidental, MD, Bijal Amin, MD, Beth N. McLellan, MD, Benedict Wu, DO, PhD

Source: JAAD Case Rep
JAAD Case Reports, Vol 62, Iss, Pp 25-27 (2025)

Subject Terms: Notes & Comments, human T-cell lymphotropic virus, cutaneous T-cell leukemia, RL1-803, subacute cutaneous lupus erythematosus, oncodermatology, cutaneous T-cell lymphoma, Dermatology

Access URL: https://doaj.org/article/884f7a3b2c0b46a2a08c771a2b589d55

Neutrophilic eccrine hidradenitis following dasatinib initiation in a patient with chronic myeloid leukemia

Authors: Avery Watson, M4, Noah Roberts, RN, BSN, M1, Caitlin Noble, MD, Hannah Badon, MD, PGY-4, Allison Cruse, MD

Source: JAAD Case Rep
JAAD Case Reports, Vol 61, Iss, Pp 18-20 (2025)

Subject Terms: drug reaction, neutrophils, RL1-803, neutrophilic eccrine hidradenitis, oncodermatology, Case Report, Dermatology

Access URL: https://doaj.org/article/b9110876f42e47468fd3ab77ca9f3e4b

Enhancing oncodermatology support: assessing patient utilization and satisfaction with educational resources for managing dermatologic toxicities of cancer treatment

Authors: Saeed, Sabrina^{Aff1, IDs00403025042623_cor1}, Chen, Tiffany X., Huggins, Lenique, Leventhal, Jonathan^{Aff2, IDs00403025042623_cor2}

Source: Archives of Dermatological Research: Founded in 1869 as Archiv für Dermatologie und Syphilis. 317(1)

Eruptive keratoacanthoma secondary to immune checkpoint inhibitors: a narrative review

Authors: Mager, Layna, Plaza, Jose A.^{Aff2, Aff3}, Sopkovich, Jennifer, Kaffenberger, Benjamin H., Dulmage, Brittany^{Aff2, IDs00403024036947_cor1}

Source: Archives of Dermatological Research: Founded in 1869 as Archiv für Dermatologie und Syphilis. 317(1)

A Review on Nutritional Deficiencies for the Inpatient Onco-Dermatologist

Authors: Ezzeddine, Farrah L.^{Aff1, Aff2}, Kumar, Madelyn^{Aff1, Aff2}, Guggina, Lauren^{Aff1, Aff2, IDs1367102500473z_cor1}

Source: Current Dermatology Reports. 14(1)

The association between multiple myeloma and melanoma: a cross-sectional study of the NIH All of Us Research Program

Authors: Valido, Kailyn, Murphy, Michael J., Langway, Jason W., Cohen, Jeffrey M., Leventhal, Jonathan S., Deverapalli, Sandhya C.^{Aff4, IDs00403025040241_cor1}

Source: Archives of Dermatological Research: Founded in 1869 as Archiv für Dermatologie und Syphilis. 317(1)

Elevated risk of oral cancer in patients with lichen planus: a retrospective cohort study

Authors: Alam, Zaryab^{Aff1, IDs00403025040763_cor1}, Alameddine, Rashwan, McKenzie, Abigail, Cherradi, Racha, Fatah, Abdelfatah, Pacha, Omar

Source: Archives of Dermatological Research: Founded in 1869 as Archiv für Dermatologie und Syphilis. 317(1)

Immune checkpoint inhibitor associated lichenoid eruptions: a review of non-steroidal systemic maintenance therapies

Authors: Tran, Richard, Toulmin, Sushila A.^{Aff2, Aff3}, Allais, Blair S., Brag, Katherine^{Aff2, Aff5}, Iriarte, Christopher^{Aff2, Aff5, IDs00520025100542_cor1}

Source: Supportive Care in Cancer. 33(11)

Immune checkpoint inhibitor associated lichenoid dermatitis mimicking erythema multiforme major with a germline variant in human leukocyte antigen-B15

Authors: Sach Thakker, Alexis Antonucci, Amin Benyounes, Blair S. Allais

Source: JAAD Case Rep
JAAD Case Reports, Vol 56, Iss, Pp 67-70 (2025)

Subject Terms: PD-1 inhibitor, drug reaction, RL1-803, erythema multiforme major, oncodermatology, Case Report, pembrolizumab, Dermatology

Access URL: https://doaj.org/article/b9ed6cd7cd604ef5b49005cba54b1b4d

Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma

Authors: Maura C. Gillis, Vanessa R. Weir, Cecilia Lezcano, Gopa Iyer, Allison Gordon

Source: JAAD Case Rep
JAAD Case Reports, Vol 56, Iss, Pp 40-44 (2025)

Subject Terms: enfortumab vedotin, bullous, dupilumab, RL1-803, oncodermatology, Case Report, pembrolizumab, Dermatology, flexural

Access URL: https://pubmed.ncbi.nlm.nih.gov/39839459
https://doaj.org/article/708d8366c0c94d88aa7d090b94ca467d

Methotrexate-induced epidermal necrosis following intrathecal chemotherapy: A case report

Authors: Brad R. Woodie, BS, Stephany L. Vittitow, MD, Sweta Subhadarshani, MD, MRCP(SCE)

Source: JAAD Case Rep
JAAD Case Reports, Vol 56, Iss, Pp 107-110 (2025)

Subject Terms: methotrexate-induced epidermal necrosis, RL1-803, oncology, leukemia, oncodermatology, Dermatology, Articles from the Oncodermotology Special Issue, toxic erythema of chemotherapy, drug eruption

Access URL: https://pubmed.ncbi.nlm.nih.gov/40034549
https://doaj.org/article/348ce8078e124e28bdf61b026a8f0295

Postradiation extragenital lichen sclerosus of the breast

Authors: Nadia Talebi, BS, McKenzie E. Maloney, BS, Rachel C. Falkner, MD

Source: JAAD Case Reports, Vol 65, Iss , Pp 4-6 (2025)

Subject Terms: EGLS, extragenital lichen sclerosus, lichen sclerosus, LS, oncodermatology, radiation, Dermatology, RL1-803

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352512625003856; https://doaj.org/toc/2352-5126

Access URL: https://doaj.org/article/e7907f652ecb4aed8696fdd8a98f5c05

Immunotherapy-induced acute generalized exanthematous pustulosis: A scoping review

Authors: Richard Tran, BA, Ryan Chen, BA, Stephanie Choi, BS, Ryan Svoboda, MD, MS, Nutan Gowda, MD

Source: JAAD Reviews, Vol 5, Iss , Pp 10-14 (2025)

Subject Terms: acute generalized exanthematous pustulosis, cutaneous immune-related adverse event, immune checkpoint inhibitor, immunotherapy, oncodermatology, Dermatology, RL1-803

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2950198925000509; https://doaj.org/toc/2950-1989

Access URL: https://doaj.org/article/e603ca6df2764c47a4cd5b11a5bf8558

Regional limb cooling for the prevention of chemotherapy-induced toxicities: a narrative review

Authors: Mallela, Teja^{Aff1, IDs0052002509689y_cor1}, Kaufman, Lily, Dulmage, Brittany

Source: Supportive Care in Cancer. 33(8)

Chilblain lupus erythematosus associated with erdafitinib therapy in a patient with metastatic bladder cancer

Authors: Amanda Truong, MD, PhD, Jennifer Liu, MD, PhD, Catherine Ni, MD, Sharona Yashar, MD

Source: JAAD Case Rep
JAAD Case Reports, Vol 54, Iss, Pp 62-65 (2024)

Subject Terms: drug reaction, erdafitinib, RL1-803, chilblain lupus, adverse reaction, cutaneous lupus, oncodermatology, Case Report, Dermatology

Access URL: https://pubmed.ncbi.nlm.nih.gov/39654848
https://doaj.org/article/111f8d759879463397ef43edac68a909

Sweet’s syndrome associated with FLT3 inhibition

Authors: Riyad N.H. Seervai, Elena Paz Munoz, S. Caleb Freeman, Ronan I. Swords, Kevin P. White, Jesse J. Keller

Source: JAAD Case Rep
JAAD Case Reports, Vol 54, Iss, Pp 89-92 (2024)

Subject Terms: quizartinib, neutrophilic dermatosis, RL1-803, cutaneous toxicity, oncodermatology, Case Report, FLT3 kinase inhibitor, Dermatology, gilteritinib

Access URL: https://pubmed.ncbi.nlm.nih.gov/39687070
https://doaj.org/article/91867e03554c40a387d982f63a7a9036